$5mill in sales for the qtr- 9 weeks of commercial launch.
Receipts of $326k from sales are purely due to payer reimbursement cycle of 45-60 days..
Cash after quarter of $65mill..
Burn rate of $20mill per qtr ($3.4mill attribute to product manufacturing).
Largely already known information here..
The big news will be an update over the coming month/months of patient uptake, then we can do the math..
Ann: March 2025 Quarterly Activities Report and Appendix 4C, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $1.980M | 6.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 1162022 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 440036 | 20 |
View Market Depth
| Last trade - 14.54pm 24/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |